MEDIFAST Business Summary

Medifast Inc. (MED) generates revenue through a direct-to-consumer model centered on its OPTAVIA brand, selling proprietary nutritional products such as "Fuelings," the OPTAVIA ACTIVE line, and the forthcoming Metabolic Synchronization system. The company’s business model relies on a coach-guided lifestyle system, utilizing a network of approximately 16,100 independent coaches to provide personalized support and behavioral frameworks. Currently, Medifast is executing a strategic pivot into the metabolic health sector, integrating its coaching network with clinical GLP-1 medical support through a partnership with LifeMD to counter the market impact of weight-loss medications. It competes directly with WW International (WeightWatchers), Nutrisystem, USANA Health Sciences, and Nu Skin Enterprises, positioning itself as a hybrid solution that bridges the gap between traditional behavioral coaching and modern clinical weight-loss interventions. Founded in 1981 by Dr. William Vitale, Medifast is currently led by Chairman and CEO Daniel Chard, who brings over 25 years of direct-selling experience from Nu Skin Enterprises and PartyLite. The company is undergoing a planned leadership transition; Nicholas Johnson, a former Nu Skin executive and Medifast’s previous Chief Field Operations Officer, was appointed President in January 2026 and is slated to succeed Chard as CEO in June 2026. The executive team includes Chief Financial Officer James Maloney, formerly of H.J. Heinz, and Chief Legal Officer Jason L. Groves. Notable governance is provided by Lead Director Jeffrey J. Brown of Brown Equity Partners, while the company maintains a strong institutional investor base including Vanguard and Charles Schwab.